Medical Developments International Limited (ASX:MVP)

Market Cap	57.46M -12.1%
Revenue (ttm)	42.57M +9.0%
Net Income	626.00K +566.0%
EPS	0.01 +562.4%
Shares Out	112.66M
PE Ratio	96.24
Forward PE	40.80
Dividend	n/a
Ex-Dividend Date	n/a

Volume	61,822
Open	0.4850
Previous Close	0.5100
Day's Range	0.4800 - 0.5000
52-Week Range	0.3650 - 0.7650
Beta	1.41
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About ASX:MVP

Medical Developments International Limited provides emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The company also supplies respiratory products, including space chambers, peak flow meters, portable nebulizers...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 68
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: MVP

Financial Performance

In fiscal year 2026, ASX:MVP's revenue was 42.57 million, an increase of 8.99% compared to the previous year's 39.06 million. Earnings were 626,000, an increase of 565.96%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 11, 2026

Data Sources Report a data error